88 related articles for article (PubMed ID: 17042916)
1. CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro.
Yuan SH; Dai DZ; Guan L; Dai Y; Ji M
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1066-72. PubMed ID: 17042916
[TBL] [Abstract][Full Text] [Related]
2. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
Karamsetty MR; Klinger JR; Hill NS
J Pharmacol Exp Ther; 2001 Jun; 297(3):968-74. PubMed ID: 11356918
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
5. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.
Itoh H; Yokochi A; Yamauchi-Kohno R; Maruyama K
Eur J Pharmacol; 1999 Jul; 376(3):233-8. PubMed ID: 10448881
[TBL] [Abstract][Full Text] [Related]
6. The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo.
Holm P; Liska J; Franco-Cereceda A
Cardiovasc Res; 1998 Mar; 37(3):765-71. PubMed ID: 9659461
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
8. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
[TBL] [Abstract][Full Text] [Related]
9. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
MacLean MR; McCulloch KM
Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
[TBL] [Abstract][Full Text] [Related]
10. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
11. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
12. The effect of the ETA receptor antagonist (CI-1020) in rats with established hypoxic pulmonary hypertension.
Sheedy W; Haleen S; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):173-6. PubMed ID: 9918751
[TBL] [Abstract][Full Text] [Related]
13. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
15. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats.
Elmedal B; de Dam MY; Mulvany MJ; Simonsen U
Br J Pharmacol; 2004 Jan; 141(1):105-13. PubMed ID: 14656807
[TBL] [Abstract][Full Text] [Related]
16. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs.
Holm P; Liska J; Clozel M; Franco-Cereceda A
J Thorac Cardiovasc Surg; 1996 Oct; 112(4):890-7. PubMed ID: 8873714
[TBL] [Abstract][Full Text] [Related]
17. Nonpeptide endothelin receptor antagonists. X. Inhibition of endothelin-1- and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Dec; 283(3):1130-7. PubMed ID: 9399985
[TBL] [Abstract][Full Text] [Related]
18. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of CI-1020, an endothelin-A receptor antagonist, in hypoxic pulmonary hypertension.
Haleen S; Schroeder R; Walker D; Quenby-Brown E; Welch K; Hallak H; Uprichard A; Keiser J
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S331-5. PubMed ID: 9595473
[TBL] [Abstract][Full Text] [Related]
20. The ETA antagonist CI-1020 inhibits hypoxic pulmonary vasoconstriction in small isolated rat pulmonary arteries.
Jones RD; Morice AH
Pulm Pharmacol Ther; 1998; 11(2-3):177-81. PubMed ID: 9918752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
